002826 易明醫藥
按盤價 
9.170 +0.660 (+7.756%)
9.170 +0.660 (+7.756%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 5.373 | 2.065 | 6.035 | 6.048 | 6.140 |
| 總資產報酬率 ROA (%) | 4.283 | 1.581 | 4.790 | 4.903 | 4.714 |
| 投入資產回報率 ROIC (%) | 5.271 | 1.971 | 5.771 | 5.571 | 5.094 | 邊際利潤分析 |
| 銷售毛利率 (%) | 66.281 | 51.189 | 43.908 | 35.909 | 35.964 |
| 營業利潤率 (%) | 13.183 | 3.524 | 6.505 | 6.704 | 7.156 |
| 息稅前利潤/營業總收入 (%) | 12.905 | 3.313 | 6.435 | 6.741 | 7.967 |
| 淨利潤/營業總收入 (%) | 11.341 | 2.358 | 5.383 | 5.993 | 6.819 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 43.717 | 82.088 | 60.710 | 42.465 | 48.394 |
| 價值變動淨收益/利潤總額(%) | 1.801 | 9.800 | 2.612 | 1.813 | 1.154 |
| 營業外收支淨額/利潤總額(%) | -0.370 | 0.401 | 1.716 | 2.752 | 8.917 | 償債能力分析 |
| 流動比率 (X) | 2.701 | 2.862 | 2.195 | 3.646 | 2.063 |
| 速動比率 (X) | 2.515 | 2.518 | 2.021 | 3.307 | 1.968 |
| 資產負債率 (%) | 20.306 | 19.152 | 26.341 | 12.658 | 24.330 |
| 帶息債務/全部投入資本 (%) | 1.057 | 1.042 | 6.217 | 0.789 | -- |
| 股東權益/帶息債務 (%) | 9,281.227 | 9,411.095 | 1,495.803 | 12,480.998 | 641.755 |
| 股東權益/負債合計 (%) | 389.638 | 419.293 | 277.879 | 687.402 | 311.009 |
| 利息保障倍數 (X) | -56.255 | -14.698 | -35.132 | -44.162 | 72.375 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 34.077 | 51.747 | 41.859 | 23.451 | 0.000 |
| 存貨周轉天數 (天) | 70.394 | 57.785 | 29.651 | 21.024 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
